1. Home
  2. NRIX vs CENT Comparison

NRIX vs CENT Comparison

Compare NRIX & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$24.94

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$43.98

Market Cap

2.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRIX
CENT
Founded
2009
1955
Country
United States
United States
Employees
N/A
6000
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NRIX
CENT
Price
$24.94
$43.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
1
Target Price
$30.50
$50.00
AVG Volume (30 Days)
1.1M
70.8K
Earning Date
04-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,987,000.00
N/A
Revenue This Year
N/A
$1.60
Revenue Next Year
$48.05
$2.04
P/E Ratio
N/A
$15.73
Revenue Growth
99.31
N/A
52 Week Low
$8.20
$28.77
52 Week High
$25.09
$45.78

Technical Indicators

Market Signals
Indicator
NRIX
CENT
Relative Strength Index (RSI) 66.01 56.00
Support Level $14.63 $42.32
Resistance Level $24.98 $45.37
Average True Range (ATR) 1.09 1.10
MACD -0.10 -0.05
Stochastic Oscillator 79.66 64.44

Price Performance

Historical Comparison
NRIX
CENT

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: